{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:58:05Z","timestamp":1792616285085,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015991","name":"Massachusetts Institute of Technology Ludwig Center for Molecular Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007375","name":"Emma and Ernesto Rulfo Association for Medical Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr Miriam & Sheldon G Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001513","name":"Breast Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.immuni.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:11:12Z","timestamp":1790867472000},"page":"2808-2823.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distant lymph nodes compensate for resected tumor-draining lymph nodes during cancer immunotherapy"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3816-6255","authenticated-orcid":false,"given":"Lutz","family":"Menzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Baish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan J.","family":"O\u2019Melia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel B.","family":"Darragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek N.","family":"Effiom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Czapla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-ji","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna J.","family":"Rajotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Nikmaneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Vander Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessalyn M.","family":"Ubellacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance L.","family":"Munn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana D.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve M.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Padera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.09.009_bib1","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2026.09.009_bib2","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.09.009_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglobulin superfamily\u2014CTLA-4","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.09.009_bib4","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.09.009_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.immuni.2026.09.009_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2026.09.009_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-bioeng-112315-031200","article-title":"The Lymphatic System in Disease Processes and Cancer Progression","volume":"18","author":"Padera","year":"2016","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.immuni.2026.09.009_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/imr.12399","article-title":"Lymph node \u2013 an organ for T-cell activation and pathogen defense","volume":"271","author":"Gasteiger","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2026.09.009_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030627","article-title":"Progression of Metastasis through Lymphatic System","volume":"10","author":"Zhou","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.immuni.2026.09.009_bib14","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41551-021-00766-1","article-title":"Solid stress impairs lymphocyte infiltration into lymph-node metastases","volume":"5","author":"Jones","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.immuni.2026.09.009_bib15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221847","article-title":"Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes","volume":"220","author":"Lei","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib16","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","article-title":"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis","volume":"185","author":"Reticker-Flynn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.09.009_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.09.009_bib18","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1126\/science.aal3662","article-title":"Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice","volume":"359","author":"Brown","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.09.009_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.aal3622","article-title":"Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice","volume":"359","author":"Pereira","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.09.009_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COC.0b013e318246b4e9","article-title":"Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes","volume":"36","author":"Alatengbaolide","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib21","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.21873\/anticanres.12801","article-title":"The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy","volume":"38","author":"Aoyama","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.immuni.2026.09.009_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0490-9","article-title":"Lymph node ratio as a prognostic factor in head and neck cancer patients","volume":"10","author":"Chen","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archsurg.2010.115","article-title":"Prognostic information from sentinel lymph node biopsy in patients with thick melanoma","volume":"145","author":"Scoggins","year":"2010","journal-title":"Arch. Surg."},{"key":"10.1016\/j.immuni.2026.09.009_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2003.10.015","article-title":"The lymph node ratio as prognostic factor in node-positive breast cancer","volume":"70","author":"Voordeckers","year":"2004","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.09.009_bib26","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.09.009_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8097","article-title":"Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation","volume":"7","author":"van Pul","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib29","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2026.09.009_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101056","article-title":"Chemotherapy but Not the Tumor Draining Lymph Nodes Determine the Immunotherapy Response in Secondary Tumors","volume":"23","author":"Zhao","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.immuni.2026.09.009_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104265","article-title":"Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors","volume":"84","author":"Yang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.immuni.2026.09.009_bib33","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.e21569","article-title":"Effect of lymph node dissection and adjuvant therapy in patients with sentinel node+ melanoma: An observational multicenter study","volume":"41","author":"Ogata","year":"2023","journal-title":"JCO"},{"key":"10.1016\/j.immuni.2026.09.009_bib34","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.immuni.2022.07.019","article-title":"Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes","volume":"55","author":"Ataide","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.09.009_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","article-title":"Same yet different\u2014how lymph node heterogeneity affects immune responses","volume":"24","author":"Cruz de Casas","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.8171322","article-title":"Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin","volume":"264","author":"De Togni","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.09.009_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.155.4.1685","article-title":"Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness","volume":"155","author":"Banks","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib38","first-page":"72","article-title":"Absence of lymph nodes in lymphotoxin-alpha(LT alpha)-deficient mice is due to abnormal organ development, not defective lymphocyte migration","volume":"45","author":"Mariathasan","year":"1995","journal-title":"J. Inflamm."},{"key":"10.1016\/j.immuni.2026.09.009_bib39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ni.3101","article-title":"The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes","volume":"16","author":"Rantakari","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-020-05661-y","article-title":"Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography","volume":"181","author":"Heydon-White","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.immuni.2026.09.009_bib41","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.bjps.2022.08.017","article-title":"A new indocyanine green fluorescence lymphography protocol for diagnostic assessment of lower limb lymphoedema","volume":"75","author":"Suami","year":"2022","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.immuni.2026.09.009_bib42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.breast.2011.10.007","article-title":"Lymphatic mapping after previous breast surgery","volume":"21","author":"Maaskant-Braat","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.immuni.2026.09.009_bib43","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.immuni.2023.06.020","article-title":"Lymph node medulla regulates the spatiotemporal unfolding of resident dendritic cell networks","volume":"56","author":"Ugur","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.09.009_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: How dendritic cells shape CD8+ T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3575","article-title":"Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy","volume":"12","author":"Francis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib46","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00262-020-02792-5","article-title":"Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC","volume":"70","author":"O\u2019Melia","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.immuni.2026.09.009_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.09.009_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd8636","article-title":"Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses","volume":"13","author":"Lo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.it.2015.10.005","article-title":"Exit Strategies: S1P Signaling and T Cell Migration","volume":"36","author":"Baeyens","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib53","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3298","article-title":"HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes","volume":"12","author":"Girard","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","article-title":"Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs","volume":"30","author":"Cyster","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","article-title":"FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function","volume":"4","author":"Brinkmann","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.immuni.2026.09.009_bib56","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s43018-022-00450-6","article-title":"A phase I\/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC","volume":"3","author":"Darragh","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.09.009_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","article-title":"The tumor-draining lymph node as a reservoir for systemic immune surveillance","volume":"10","author":"Delclaux","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.immuni.2026.09.009_bib58","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210749","article-title":"In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue","volume":"219","author":"Li","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib59","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib60","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1470-2045(20)30494-0","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"21","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.22.00533","article-title":"Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)","volume":"41","author":"Weber","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00036","article-title":"Growth and Immune Evasion of Lymph Node Metastasis","volume":"8","author":"Jones","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.09.009_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1367-0","article-title":"Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence","volume":"14","author":"Sato","year":"2019","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.immuni.2026.09.009_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2026.09.009_bib66","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04388-x","article-title":"Role of tertiary lymphoid organs in the regulation of immune responses in the periphery","volume":"79","author":"Bery","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.immuni.2026.09.009_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1293\/tox.2016-0075","article-title":"The lymphoid system: a review of species differences","volume":"30","author":"Haley","year":"2017","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.immuni.2026.09.009_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051362","article-title":"Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review","volume":"9","author":"Onoi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.immuni.2026.09.009_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103663","article-title":"Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update","volume":"173","author":"Boukouris","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.immuni.2026.09.009_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/math8122236","article-title":"Graph Theory for Modeling and Analysis of the Human Lymphatic System","volume":"8","author":"Savinkov","year":"2020","journal-title":"Mathematics"},{"key":"10.1016\/j.immuni.2026.09.009_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/a16030168","article-title":"Network Modeling of Murine Lymphatic System","volume":"16","author":"Grebennikov","year":"2023","journal-title":"Algorithms"},{"key":"10.1016\/j.immuni.2026.09.009_bib72","first-page":"69","article-title":"THE LYMPH SYSTEM IN MICE","volume":"12","author":"Kawashima","year":"1964","journal-title":"Jpn. J. Vet. Res."},{"key":"10.1016\/j.immuni.2026.09.009_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jim.2006.01.022","article-title":"Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB\/cAnNCrl mice","volume":"312","author":"Van Den Broeck","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.immuni.2026.09.009_bib74","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jim.2007.11.012","article-title":"Lymph node mapping in the mouse","volume":"332","author":"Harrell","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.immuni.2026.09.009_bib75","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PRS.0000000000003776","article-title":"Lymphatic Territories (Lymphosomes) in the Rat: An Anatomical Study for Future Lymphatic Research","volume":"140","author":"Suami","year":"2017","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.immuni.2026.09.009_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1524-4741.2007.00401.x","article-title":"HIV-Associated Intramammary Lymphadenopathy","volume":"13","author":"Konstantinopoulos","year":"2007","journal-title":"Breast J."},{"key":"10.1016\/j.immuni.2026.09.009_bib77","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00005537-199903000-00005","article-title":"Quantification of lymph nodes in selective neck dissection","volume":"109","author":"Friedman","year":"1999","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.immuni.2026.09.009_bib78","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/hed.21089","article-title":"Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck","volume":"31","author":"Reynolds","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.immuni.2026.09.009_bib79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1469-7580.2009.01183.x","article-title":"Functional anatomy of the lymphatics draining the skin: a detailed statistical analysis","volume":"216","author":"Reynolds","year":"2010","journal-title":"J. Anat."},{"key":"10.1016\/j.immuni.2026.09.009_bib80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0026-2862(89)90074-5","article-title":"Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection","volume":"37","author":"Baxter","year":"1989","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.immuni.2026.09.009_bib81","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0021-9290(99)00125-6","article-title":"Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation","volume":"32","author":"Swartz","year":"1999","journal-title":"J. Biomech."},{"key":"10.1016\/j.immuni.2026.09.009_bib82","series-title":"Transport Phenomena in Biological Systems","author":"Truskey","year":"2009"},{"key":"10.1016\/j.immuni.2026.09.009_bib83","article-title":"Exercising and Compression Mechanism in the Treatment of Lymphedema","volume":"13","author":"Barufi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.immuni.2026.09.009_bib84","doi-asserted-by":"crossref","first-page":"111e","DOI":"10.1097\/PRS.0000000000002258","article-title":"Diagnosis and Management of Obesity-Induced Lymphedema","volume":"138","author":"Greene","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.immuni.2026.09.009_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70043","article-title":"Exercise-Induced Cardiac Lymphatic Remodeling Mitigates Inflammation in the Aging Heart","volume":"24","author":"Roh","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.immuni.2026.09.009_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00459","article-title":"Regulation of Lymphatic Function in Obesity","volume":"11","author":"Kataru","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.immuni.2026.09.009_bib87","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041176","article-title":"Lymphedema and Obesity","volume":"12","author":"Sudduth","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326003845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326003845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:31:34Z","timestamp":1792614694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326003845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":87,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1074761326003845"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.09.009","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distant lymph nodes compensate for resected tumor-draining lymph nodes during cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}